4 Healthcare Stock Stories Demanding Investor Focus

Celgene Corporation (NASDAQ:CELG): Current price $101.03

The company reported Wednesday that it has entered into an accelerated share repurchase arrangement with an investment bank so as to buy back a total of $600 million of its common stock. The plan is part of the existing board-authorized share repurchase program. Thus far in 2013, Celgene has repurchased roughly $385 million of its common stock and has about $1,450 million remaining in the ongoing program.